<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07649993626199</udiDi>
    <basicUdiDi>7649993626FT42305VL</basicUdiDi>
    <tradeName>Sorisen</tradeName>
    <deviceName>Sorisen</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M9002</emdnCode>
    <emdnDescription>PROTECTIVE DEVICES, LUBRICANTS AND SOOTHING DEVICES (SPRAYS, GELS, FLUIDS AND CREAMS)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C43E07L100</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:54:02.068Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993626151</udiDi>
    <basicUdiDi>7649993626FT42303VG</basicUdiDi>
    <tradeName>Dermasectan</tradeName>
    <deviceName>Dermasectan</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>M9002</emdnCode>
    <emdnDescription>PROTECTIVE DEVICES, LUBRICANTS AND SOOTHING DEVICES (SPRAYS, GELS, FLUIDS AND CREAMS)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C41E07L003</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:54:01.253Z</lastUpdated>
  </row>
  <row>
    <udiDi>04002448176824</udiDi>
    <basicUdiDi>7649993626FT42301VC</basicUdiDi>
    <tradeName>GAVIDARM HÄUFIGER DURCHFALL</tradeName>
    <deviceName>Gelsectan</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C05B02E030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:48:32.635Z</lastUpdated>
  </row>
  <row>
    <udiDi>04002448176817</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gavidarm Häufige Verstopfung</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:48:31.838Z</lastUpdated>
  </row>
  <row>
    <udiDi>03059940049591</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>GAVIDigest FLATULENCES &amp; BALLONNEMENTS</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>C12B02E003</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T03:48:31.163Z</lastUpdated>
  </row>
  <row>
    <udiDi>08428076010365</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Gavidigest Gases e hinchazon</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E03</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:25:57.763Z</lastUpdated>
  </row>
  <row>
    <udiDi>08428076009208</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Gavidigest Gases e hinchazon</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E030</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:25:55.261Z</lastUpdated>
  </row>
  <row>
    <udiDi>08428076009192</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gavidigest Estrenimiento</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E030</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:25:49.290Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055719118494</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Gaviscon Intestino Gonfiore e meteorismo</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E003</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:07:04.147Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055719116322</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Gaviscon Intestino Gonfiore e meteorismo</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E030</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:05:10.390Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055719116292</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gaviscon Intestino Stitichezza</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E030</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:05:09.262Z</lastUpdated>
  </row>
  <row>
    <udiDi>08050624486546</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gaviscon Intestino Stitichezza</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E008</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:02:16.076Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993626250</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Lefaxan Protect</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>F12B02E015</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:39.661Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993626236</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Lefaxan Protect</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E030</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:33.648Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993626229</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Lefaxan Protect</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E015</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:32.456Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993626137</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>SECTACOL</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E003</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:31.250Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993626113</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gelselax</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E030</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:30.045Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993626106</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gelselax</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E015</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:24.045Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993626090</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gelselax</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E008</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:22.849Z</lastUpdated>
  </row>
  <row>
    <udiDi>07649993626076</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>SECTACOL</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E030HU</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:13:21.653Z</lastUpdated>
  </row>
</eudamedExport>